Table 1.
Demographics and tumor characteristics, 5-year survivors of AYA cancer diagnosed 1975–2012, SEER-9.
| Characteristic | n (%) or (Standard Deviation) |
|---|---|
| Total | 162,317 |
| Median follow-up, years | 17.4 (9.9) |
| Age, years | |
| 15–19 | 10,493 (6.5) |
| 20–29 | 47,760 (29.4) |
| 30–39 | 104,064 (64.1) |
| Sex | |
| Male | 61,085 (37.6) |
| Female | 101,232 (62.4) |
| Race | |
| White | 134,816 (83.0) |
| Black | 13,388 (8.2) |
| API/AI/AN | 12,054 (7.4) |
| Unknown | 2059 (1.3) |
| Cancer site | |
| Bone/soft tissue sarcoma 1 | 7589 (4.7) |
| Breast, female | 25,104 (15.5) |
| Cervical/uterine | 12,538 (7.7) |
| Hodgkin lymphoma | 12,687 (7.8) |
| Non-Hodgkin lymphoma | 8502 (5.2) |
| Melanoma | 23,039 (14.2) |
| Testicular germ cell | 15,274 (9.4) |
| Thyroid | 21,055 (13.0) |
| Other 1 | 36,529 (22.5) |
| Stage | |
| Localized | 94,699 (58.3) |
| Regional | 37,639 (23.2) |
| Distant | 16,099 (9.9) |
| Unstaged/Unknown | 13,869 (8.5) |
| Not recorded | 11 (0.0) |
1 Excluding Kaposi sarcoma; AYA = adolescent and young adult; API = Asian/Pacific Islander; AI = American Indian; AN = Alaska Native.